10. Fentora - Top 10 Warnings and Recalls

Drug: Fentora

2006 sales: $370 million

Manufacturer: Cephalon

Safety concern: Warning; improper dosing leading to death

Related Articles:
> New warning for off-label Fentora. Report
> Red flags raised on Fentora misuse. Report
> FDA approves Fentora for cancer pain. Report
> Cephalon shares jump on Fentora decision. Report
> Cephalon takes heat for off-label narcotic promotion. Report

10. Fentora - Top 10 Warnings and Recalls
Read more on

Suggested Articles

Lilly
Marketing

Eli Lilly, Innovent tout Tyvyt's front-line NSCLC win

In previously untreated nonsquamous NSCLC, a Tyvyt-chemo combo beat chemo alone at stalling the time to tumor progression or death.

by Angus Liu
opdivo
Pharma

BMS' Opdivo-Yervoy duo slashes mesothelioma death risk by 26%

It’s been a big year for Bristol's Opdivo-Yervoy combo in lung cancer, but with new mesothelioma data in hand, the duo isn’t done making headlines.

by Carly Helfand
Pharma

Roche set to take on Biogen, Novartis in SMA with Evrysdi

A third spinal muscular atrophy treatment option is set to debut with the FDA’s approval for Roche’s Evrysdi, formerly known as risdiplam.

by Eric Sagonowsky